{"organizations": [], "uuid": "75bb36b7a9817df8c0087974d318c52de877fad4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/15/globe-newswire-titan-medical-announces-director-resignation.html", "country": "US", "domain_rank": 767, "title": "Titan Medical Announces Director Resignation", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-16T00:15:00.000+02:00", "replies_count": 0, "uuid": "75bb36b7a9817df8c0087974d318c52de877fad4"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/15/globe-newswire-titan-medical-announces-director-resignation.html", "ord_in_thread": 0, "title": "Titan Medical Announces Director Resignation", "locations": [], "entities": {"persons": [{"name": "john e. barker", "sentiment": "none"}, {"name": "martin bernholtz", "sentiment": "none"}], "locations": [{"name": "toronto", "sentiment": "none"}], "organizations": [{"name": "tmd", "sentiment": "negative"}, {"name": "titan medical inc.", "sentiment": "negative"}, {"name": "titan medical inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "TORONTO, March 15, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that Martin Bernholtz has resigned from his positions as director and Chairman of the Company.\nMartin Bernholtz was the longest serving member of Titan’s board of directors, having joined in 2008. The Company thanks him for his past service and wishes him all the best in the future. Director John E. Barker will assume the position of chairman of the Company on an interim basis, effective immediately.\nAbout Titan Medical Inc.\nTitan Medical Inc. is focused on research and development through to the planned commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery. The Company is developing the SPORT Surgical System, a single-port robotic surgical system. The SPORT Surgical System is comprised of a surgeon-controlled patient cart that includes a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides an advanced ergonomic interface to the patient cart and a 3D endoscopic view inside the patient’s body. Titan intends to pursue a broad set of surgical indications for the SPORT Surgical System, including general abdominal, gynecologic and urologic procedures.\n please visit the Company’s website at www.titanmedicalinc.com .\nForward-Looking Statements\nThis news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements, including statements with respect to the use of the net proceeds of the Offering and the anticipated listing of the Common Shares on the TSX, reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the “Risk Factors” section of the Company’s Annual Information Form dated March 31, 2017 (which may be viewed at www.sedar.com ). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.\nContacts:\nLHA Investor Relations\nKim Sutton Golodetz\n(212) 838-3777\nkgolodetz@lhai.com\nor\nBruce Voss\n(310) 691-7100\nbvoss@lhai.com\nSource:Titan Medical Inc.", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/77d19b97-829a-42d8-9d09-dabd47bc0315"], "published": "2018-03-16T00:15:00.000+02:00", "crawled": "2018-03-16T00:22:23.000+02:00", "highlightTitle": ""}